Related Experiment Video
Updated: Jul 15, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
[Risk factors for coronary artery disease stimulate urokinase receptor expression on monocytes]
Wei Chen1, Lian-feng Chen, Wen-ling Zhu
1Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Insights
Coronary artery disease risk factors like dyslipidemia and obesity significantly increase urokinase receptor (uPAR) expression on monocytes. This finding highlights uPAR as a potential biomarker for cardiovascular disease risk.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Biology
Context:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Monocytes play a crucial role in the inflammatory processes underlying atherosclerosis.
- Urokinase receptor (uPAR) is implicated in cell adhesion, migration, and matrix degradation, processes relevant to atherogenesis.
Purpose:
- To investigate the association between common coronary artery disease (CAD) risk factors and the expression of urokinase receptor (uPAR) on monocytes.
- To quantify uPAR expression levels in monocytes across different combinations of CAD risk factors.
Summary:
- A study of 106 patients with CAD risk factors (hypertension, dyslipidemia, obesity) and 17 healthy controls measured monocyte uPAR expression via flow cytometry.
- Elevated uPAR expression was observed in patients with dyslipidemia and obesity, particularly when these factors were combined.
- uPAR expression showed a significant correlation with fasting blood glucose in the dyslipidemia group.
Impact:
- Findings suggest that dyslipidemia and obesity contribute to increased uPAR expression on monocytes in patients with CAD risk factors.
- Elevated monocyte uPAR may serve as a potential biomarker for assessing cardiovascular disease risk.
- Further research into the role of uPAR in CAD pathogenesis could reveal novel therapeutic targets.
Objective:
To evaluate the effect of risk factors for coronary artery disease (CAD) on urokinase receptor (uPAR) expression on monocytes.
Methods:
A total of 106 patients were enrolled and divided into five risk-factor groups: sixteen with hypertension, twenty-four with dyslipidemia, eighteen with hypertension + obesity, eighteen with dyslipidemia + obesity and thirty with hypertension + dyslipidemia + obesity. Seventeen healthy volunteers were recruited as control group. Monocyte expression of uPAR and mean fluorescence intensity index (MFI Index) of uPAR were measured by flow cytometer (FACSCalibur).
Results:
No difference in monocyte uPAR expression was detected between hypertension and control group [(4.9 +/- 12.5)% vs. (7.7 +/- 10.3)%, P=0.74]. However, the uPAR expression was raised to (23.7 +/- 22.5)% in hyperlipidemia group, a 3.9- and a 2.1-fold increase compared with those in hypertension (P<0.01) and control group (P<0.05), respectively. When combined with obesity, uPAR expression was elevated further to (32.9 +/- 30.8)% in hypertension + obesity group, (37.4 +/- 31.4)% in dyslipidemia + obesity group and (23.8 +/- 20.5)% in hypertension + dyslipidemia + obesity group, all having statistical significance compared with control group or hypertension group (P<0.01). The results were the same when corrected by age, BMI and hs-CRP. uPAR MFI Index was increased from 0.78 +/- 0.86 in control group to 1.91 +/- 1.97 and 3.33 +/- 2.52 in dyslipidemia group and hypertension + obesity group, respectively, P<0.05. Linear regression analysis revealed a significant correlation between uPAR expression and FBG concentration in dyslipidemia group, r=0.72, P=0.04.
Conclusions:
uPAR expression was elevated on monocytes in patients with risk factors for CAD. Dyslipidemia and obesity may contribute to the increase of uPAR expression.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease I: Introduction
